1. 2 Global Travel – who goes? 3 Global Links of NDM to the UK Kumarasamy et al., Lancet Infect Dis 2010 10:597-602.

Slides:



Advertisements
Similar presentations
National Reporting & Learning System (NRLS) Reporting systems are vital in providing a core of sound, representative information on which to base analysis.
Advertisements

New Challenges in M&E Lets go. Scaling Up Monitoring & Evaluation Strategic Information PROGRAM GUIDANCE RESULT NEEDS OPPORTUNITIES Resources New directions.
Developments from the National Quality Board: A New Objective for MRSA Derek Butler Registered Charity No
Dr. E. Anne Peterson, MD, MPH Assistant Administrator, Bureau for Global Health, USAID Sustainable Investment and Donor Coordination Stop TB Partners Forum.
BEST PRACTICES: MRSA PRECAUTIONS Dr. Elizabeth Bryce.
DO HEALTHY CHILDREN NEED TO GET VACCINATED?. Rationale for childhood vaccination Annual influenza vaccine is widely recommended for children at high risk.
The Rise of Carbapenem Resistant Organisms
Scottish Infection Research Network Research Consortia.
Pneumonia Sapna Bamrah, MD CDC
THE EPIDEMIOLOGY OF HIV/AIDS. HIV/AIDS – USA 2009 Living with HIV/AIDS = 1.2 million Incidence = 56,000/year MSM = 53% Heterosexuals = 31% IDUs.
Antimicrobial resistance “One health fits all”
APIC Chapter 13 Journal Club April 15, 2015
Technical Advisory Group meeting, WHO/WPRO
Antibiotic overuse and misuse in long term care Shira Doron, MD Assistant Professor of Medicine Division of Geographic Medicine and Infectious Diseases.
Claire Boville – Department of Health
FALL 2010 Course: Biology 225 Instructor: Dr. Janie Sigmon Hot Topics in Microbiology.
1 Can the strict search-and-isolate strategy for controlling the spread of highly-resistant bacteria be mitigated? G Birgand a, I Lolom a, E Ruppe b, L.
Ecdc.europa.eu Tommi Asikainen, Tubingen, 22 October 2008 European Centre for Disease Prevention and Control FUTURE DISEASE CHALLENGES IN EUROPE – where.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Can the Application of the International Health Regulations to Antimicrobial Resistance Events Help to Preserve Antimicrobials? AMR 1, abstract N° 406.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
Monitoring UA 2010 in health sector 1 |1 | Monitoring progress towards Universal Access 2010 in the health sector Kevin M De Cock Ties Boerma.
Department of Health Stakeholder Conference Inmarsat, Wednesday 30 th July 2008 Derek Butler Chair MRSA Action UK
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver” Elizabeth J. Phillips, MD, FRCPC,FRACP, FACTM Professor & Director, Centre for Clinical.
Vivienne Evans. Nearly 1.5 million adults will be significantly affected by a relative’s drug use The cost of harms they experience as a result amounts.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
What’s happening now ? Epidemiology of (carbapenem) resistance Neil Woodford HPA – AMRHAI - Colindale.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Infection Prevention and Control Mandatory Update for Clinical Staff 2014.
Globalization and the U.S. Economy You’reYou’re Living It!
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Figures Slideset.
MUDr. Markéta Petrovová Dpt. of occupational medicine LF MU Brno 2011.
Information in a Multi-Disciplinary World MARIE WASHBROOK Head of Nursing & Allied Clinical Relations.
European Centre for Disease Prevention and Control
30mm 10mm logo safe area 10mm logo safe area EDITING NOTES All copy must stay within the content limit guidelines. Any image added to a slide with text.
European approaches to MDR- GNR prevention and control Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust Blog:
The role of PHE’s AMRHAI Reference Unit Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit © Crown.
Containing CRE spread Jon Otter, PhD FRCPath Scientific Director, Healthcare, Bioquell Research Fellow, King’s College London
Part III Key Strategies for Combating Resistance.
MRSA: To isolate or not to isolate? Jean-François TIMSIT, MD PhD Medical ICU, University hospital Grenoble, France INSERM U 578 ESICM Barcelona – Sept.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Infection Prevention and Control Mandatory Update for Clinical Staff 2014.
Northern Dimension Antibiotic Resistance Study NoDARS Prof Jaana Vuopio, M.D., Ph.D., PAC 11 side-event, 19 November 2015, Berlin, Germany.
The Impact of Migration on TB Epidemiology in Europe
Carbapenem Resistant Enterobacteriaceae:
Overview of guidance/frameworks
Improving Infection Prevention & Control Practices
Professor Alan Johnson Department of HCAI & AMR
Managing repeated screening for known CPE carriers: once positive always positive? Siddharth Mookerjee, Eleonora Dyakova, Frances Davies, Kathleen Bamford,
This is an archived document.
GNBSI Can we really halve GNBSIs? Jon Otter, PhD FRCPath
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
Promiscuous plasmids? Scaling infection control implications of horizontal spread of carbapenemase genes between species Siddharth Mookerjee, Frances Davies,
Using the Toolkit to build a CPE policy
Risk factors for carbapenem-resistant Enterobacteriaceae (CRE) carriage at the time of hospital admission Siddharth Mookerjee,1 Eleonora Dyakova,1 Frances.
Carbapenem-resistant Gram-negative bacteria
Call topic identification for 2019 call
Changes to 10A NCAC 41A May 5, 2018.
Cost utility of alternative Carbapenemase
The challenges of multi-drug-resistance in hepatology
ДЭМБ, Сүрьеэтэй тэмцэх стратеги он: Бүсийн хэтийн төлөвлөгөө
Overseas travel and antibiotic use are more important than community demographics or measures of social and material deprivation in predicting ESBL colonization.
Antibiotic Resistance: Strategic Solutions
SUPERBUGS: STRUMENTI DI INTERVENTO NELL’ERA POST-ANTIBIOTICA
To screen or not to screen for VRE in immunocompromised patients?
CPE: coming to a hospital near you!
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver”
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
Fighting MDR G-Negative Infections
Presentation transcript:

1

2 Global Travel – who goes?

3 Global Links of NDM to the UK Kumarasamy et al., Lancet Infect Dis :

4 15 million Visitors to the UK 2011 Country Rank (by number) Visitors (000) USA12,484 Italy71,526 India16350 Brazil19276 Greece25225 Israel31164 China33149 Nigeria34142 Pakistan4865

Visitors to the UK by Purpose – potential for MDR GN household spread

Patient Number Patient No’s Total completed NHS admission episodes in England 2011* 14,890,844 Total admissions UCLH**127,364 Total overseas**1631 Total transferred from another NHS provider** 19 Total transferred from a private provider** 8 Total overseas patients transferred from private provider** 0 Total projected overseas patient admissions 190,751 *HES Data ** P. Wilson Pers Comm Potential Impact of Overseas Patients

7 Carbapenemase-producing Enterobacteriaceae in the UK (n = 1659) Neil Woodford: AMRHAI, Unpublished data Early cases often imported Imported & ‘home grown’

Currently very limited knowledge on basic epidemiology. CRO carriage rates in specific high risk groups allowing targeted screening? CRO carriage rates in specific high risk groups allowing targeted screening? Duration of carriage? Duration of carriage? Optimal method of patient screening – rectal swabs – reliability of self swabbing? Optimal method of patient screening – rectal swabs – reliability of self swabbing? Optimal laboratory screening method? Optimal laboratory screening method? Transmission rates in home/hospital? Transmission rates in home/hospital? Efficacy of decolonisation and isolation? Efficacy of decolonisation and isolation? Cost effectiveness of interventions? Cost effectiveness of interventions?

9 Political Commitment & Investment Aggressive Infection..Control Screening Isolation Reinforced Hand..Hygiene Contact precautions Surveillance Targeted & Structured Concerted Action Required: ALL Sectors Focussed Clinical Research Cross Cutting Antibiotic Policy Antimicrobial Stewardship Simpler cheaper laboratory tests Centralised Reporting incl private sector Unified Strategic Policy in DH/NHS Renewed Drug Pipeline Improved Global Intelligence

10 What is the key priority ? Refocus NHS Infection Prevention and Control onto MDR GNB

11 Serious threat to routine care in the NHS